These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27134256)

  • 1. Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry.
    Curtis JR; Bharat A; Chen L; Greenberg JD; Harrold L; Kremer JM; Sommers T; Pappas D
    J Rheumatol; 2016 Jun; 43(6):1027-9. PubMed ID: 27134256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review.
    Curtis JR; Bykerk VP; Aassi M; Schiff M
    J Rheumatol; 2016 Nov; 43(11):1997-2009. PubMed ID: 27803341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and perception of methotrexate treatment information in people with rheumatoid arthritis.
    Leonardo N; Lester S; Graham M; Barrett C; Whittle S; Rowett D; Buchbinder R; Hill CL
    Int J Rheum Dis; 2020 Jun; 23(6):805-812. PubMed ID: 32537893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of methotrexate adherence in rheumatoid arthritis patients.
    De Cuyper E; De Gucht V; Maes S; Van Camp Y; De Clerck LS
    Clin Rheumatol; 2016 May; 35(5):1335-9. PubMed ID: 26781783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
    Saraux A; Devauchelle-Pensec V; Engerran L; Flipo RM
    J Rheumatol; 2006 Jul; 33(7):1258-65. PubMed ID: 16783865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and Rheumatologist Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis.
    Owensby JK; Chen L; O'Beirne R; Ruderman EM; Harrold LR; Melnick JA; Safford MM; Curtis JR; Danila MI
    Arthritis Care Res (Hoboken); 2020 Jul; 72(7):933-941. PubMed ID: 31008566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to current recommendations on the use of methotrexate in rheumatoid arthritis in Italy: results from the MARI study.
    Manara M; Bianchi G; Bruschi E; Azzolini V; Belai Beyene N; Corbanese S; De Gennaro F; Martin-Martin LS; Molica Colella AB; Pozzi MR; Romeo N; Rossini T; Severino A; Sinigaglia L
    Clin Exp Rheumatol; 2016; 34(3):473-9. PubMed ID: 27050478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey on the medication adherence to methotrexate among rheumatoid arthritis patients treated with self-administered biologic drugs.
    Aaltonen KJ; Turunen JH; Sokka T; Puolakka K; Valleala H
    Clin Exp Rheumatol; 2016; 34(4):694-7. PubMed ID: 27213997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis.
    Valerio V; Kwok M; Loewen H; Winkler J; Mody GM; Scuccimarri R; Meltzer M; Mengistu Y; Feldman CH; Weinblatt ME; Lacaille D; Hitchon CA; Colmegna I
    Clin Rheumatol; 2021 Apr; 40(4):1259-1271. PubMed ID: 32876784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
    Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
    J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: A qualitative study.
    Heidari P; Cross W; Weller C; Team V; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Sep; 22(9):1695-1705. PubMed ID: 31322831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.
    Bonafede M; Johnson BH; Tang DH; Shah N; Harrison DJ; Collier DH
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1656-63. PubMed ID: 26097194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.
    Sauer BC; Teng CC; Tang D; Leng J; Curtis JR; Mikuls TR; Harrison DJ; Cannon GW
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):313-322. PubMed ID: 27273801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.
    Cardiel MH; Pons-Estel BA; Sacnun MP; Wojdyla D; Saurit V; Marcos JC; Pinto MR; Cordeiro de Azevedo AB; da Silveira IG; Radominski SC; Ximenes AC; Massardo L; Ballesteros F; Rojas-Villarraga A; Oñate RV; Hernandez MP; Esquivel-Valerio JA; García-De La Torre I; Khoury VJ; Millán A; Soriano ER;
    J Clin Rheumatol; 2012 Oct; 18(7):327-35. PubMed ID: 23047532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
    Sokka T; Pincus T
    J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Chakravarty EF; Sanchez-Yamamoto D; Bush TM
    J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.